- Home
- A-Z Publications
- Current Computer - Aided Drug Design
- Previous Issues
- Volume 20, Issue 1, 2024
Current Computer - Aided Drug Design - Volume 20, Issue 1, 2024
Volume 20, Issue 1, 2024
-
-
Network Pharmacology Study to Reveal the Mechanism of Zuogui Pill for Treating Osteoporosis
Authors: Gaoxiang Wang, Huilin Li, Hengxia Zhao, Deliang Liu, Shufang Chu, Maosheng Lee and Zebin FangBackground To our knowledge, there is still a lack of scientific reports on the pharmacological mechanism of the Zuogui Pill (ZGP) for treating osteoporosis (OP). Aims This study aimed to explore it via network pharmacology and molecular docking. Methods We identified active compounds and associated targets in ZGP via two drug databases. Disease targets of OP were obtained utilizing five disease databases. Networks w Read More
-
-
-
The Therapeutic Effect and Potential Pharmacological Mechanisms of Ding-Zhi-Xiao-Wan on Depression were Investigated by Meta-analysis, Network Pharmacology and Molecular Docking
Authors: Li-Li Lin, Han-Biao Wu and Zhi-Kun QiuIntroduction Ding-Zhi-Xiao-Wan (DZXW) produces potential antidepressant-like effects. However, its antidepressant mechanisms are still unclear. Objective To analyze the antidepressant effects and the pharmacological mechanisms of DZXW, meta-analysis, network pharmacology, and molecular docking were selected in this study. Methods The compounds of DZXW and genes associated with compounds or depression Read More
-
-
-
Graph Convolutional Capsule Regression (GCCR): A Model for Accelerated Filtering of Novel Potential Candidates for SARS-CoV-2 based on Binding Affinity
Authors: Aravind Krishnan and Dayanand VinodBackground There has been a growing interest in discovering a viable drug for the new coronavirus (SARS-CoV-2) since the beginning of the pandemic. Protein-ligand interaction studies are a crucial step in the drug discovery process, as it helps us narrow the search space for potential ligands with high drug-likeness. Derivatives of popular drugs like Remdesivir generated through tools employing evolutionary algorithms Read More
-
-
-
Tacrolimus and Azole Derivatives of Agricultural and Human Health Importance: Prediction of ADME Properties
Authors: Lyudmyla Antypenko, Konstyantyn Shabelnyk and Sergiy KovalenkoIntroduction Agricultural chemicals are impacting health nowadays. Recently, promising synergistic antifungal interaction between tacrolimus and some azole compounds was studied. Objective To determine ADME parameters, potential side effects of test substances to reduce time and resources in the future. Methods All descriptors and molecular parameters were obtained by the protocols ofSwissADME and ProTox II. R Read More
-
-
-
Molecular Mechanism of Caulis Spatholobi in the Treatment of Chronic Myeloid Leukemia based on Network Pharmacology and Experimental Verification
Authors: Yanchun Wu, Fangfang Lian, Hongxia Chen, Chaoyu Zhang, Linli Wei and Hui TianBackground Caulis Spatholobi is one of the necessary Chinese herbal medicines for hematologists in the treatment of malignant tumors, but its potential targets and molecular mechanisms need further exploration. Objective This study aimed to predict the relevant targets of the treatment of chronic myeloid leukemia (CML) with Caulis Spatholobi by applying the network pharmacology method, and in vitro cell experiments Read More
-
-
-
Novel 1-H Phenyl Benzimidazole Derivatives for IBD Therapy - An in-vitro and in-silico Approach to Evaluate its Effects on the IL-23 Mediated Inflammatory Pathway
Authors: V. Vishnu, P. R. Krishnendu, Subin Mary Zachariah and Kanthlal S. K.Objective IBD is a chronic idiopathic gut condition characterised by recurring and remitting inflammation of the colonic mucosal epithelium. Benzimidazole is a prominent and attractive heterocyclic compound with diverse actions. Although seven locations in the benzimidazole nucleus can be changed with a number of chemical entities for biological activity, benzimidazole fused with a phenyl ring has caught our interest Read More
-
-
-
Development of Potential Inhibitors for Human T-lymphotropic Virus Type I Integrase Enzyme: A Molecular Modeling Approach
Introduction Integration of viral DNA into the host cell genome, carried out by the HTLV-1 integrase enzyme, is a crucial step in the Human T-lymphotropic Virus type I (HTLV-1) life cycle. Thus, HTLV-1 integrase is considered an attractive therapeutic target; however, no clinically effective inhibitors are available to treat HTLV-1 infection. Objective The main objective was to identify potential drug-like compounds capable of Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cad
Journal
10
5
false
en
